The Hill publishes NORD op-ed: Congress must act now to help 15 million sick children
September 15, 2016
By Christi Jensen
Categories: NORD News
The Hill, a top U.S. political website, read by Congressional offices, the White House, political pundits, and more, today published the following op-ed by NORD President and CEO, Peter L. Saltonstall, urging Congress to reauthorize the Rare Pediatric Disease Priority Review Voucher (PRV) program.
The PRV program encourages the development of therapies for children with rare diseases. More than half of the 30 million Americans with rare diseases are kids. The majority of rare diseases have no treatment.
We need your help! Congress can reauthorize the program but must act before September 30 when the bill is set to expire. Make sure this bill does not cease to exist. Please join us in advocating for the reauthorization of this important program. Click here to tell your Senators to pass this bill today.
The following op-ed was originally published in The Hill: http://thehill.com/blogs/congress-blog/healthcare/296004-congress-must-act-now-to-help-15-million-sick-children
Tags: Abeona Therapeutics, Advancing Hope Act of 2016, Advancing Hope Act of 2016 (S.1878), advocacy alert, Batten Disease, Congress, duchenne muscular dystrophy, epidermolysis bullosa, George Soros, Krabbe disease, metachromatic leukodystrophy, Nationwide Children’s Hospital, op-ed, Orphan Drug Act, Peter L. Saltonstall, Progeria, PRV Program, Rare Pediatric Disease Priority Review Voucher Program, S.1878, Sanfilippo Syndrome, Sly syndrome, Spinal Muscular Atrophy, Spinocerebellar ataxia autosomal recessive 9 (SCAR9), The Hill, TK2 Mitochondrial DNA Depletion Syndrome